1. 21P Peripheral pre-existing T cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients. (December 2022) Authors: Xagara, A.; Fortis, S.; Goulielmaki, M.; Koinis, F.; Chantzara, E.; Samaras, I.; Papadopoulos, V.N.; Georgoulias, V.; Baxevanis, C.N.; Kotsakis, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib. (February 2017) Authors: Messaritakis, I.; Politaki, E.; Plataki, M.; Karavassilis, V.; Kentepozidis, N.; Koinis, F.; Samantas, E.; Georgoulias, V.; Kotsakis, A. Journal: Lung cancer Issue: Volume 104(2017) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lung cancer and tobacco smoking in Crete, Greece: reflections from a population-based cancer registry from 1992 to 2013. Issue 1 (December 2017) Authors: Sifaki-Pistolla, D.; Lionis, C.; Georgoulias, V.; Kyriakidis, P.; Koinis, F.; Aggelaki, S.; Tzanakis, N. Journal: Tobacco induced diseases Issue: Volume 15:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders. (February 2017) Authors: Gadgeel, S.M.; Soria, J.C.; Felip, E.; Cobo, M.; Lu, S.; Syrigos, K.; Lee, K.H.; Göker, E.; Georgoulias, V.; Li, W.; Guclu, S.; Isla, D.; Ardizzoni, A.; Dupuis, N.; Gibson, N.; Krämer, N.; Bühnemann, C.; Solca, F.; Ehrnrooth, E.; Goss, G. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). Issue 1 (April 2015) Authors: Kotsakis, A.; Kentepozidis, N.; Emmanouilidis, Ch.; Polyzos, A.; Agelidou, A.; Vaslamatzis, M.; Chandrinos, V.; Agelaki, S.; Vamvakas, L.; Kalbakis, K.; Katsaounis, P.; Stoltidis, D.; Nintos, G.; Hatzidaki, D.; Vetsika, E.K.; Mavroudis, D.; Georgoulias, V. Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). Issue 1 (April 2015) Authors: Kotsakis, A.; Kentepozidis, N.; Emmanouilidis, Ch.; Polyzos, A.; Agelidou, A.; Vaslamatzis, M.; Chandrinos, V.; Agelaki, S.; Vamvakas, L.; Kalbakis, K.; Katsaounis, P.; Stoltidis, D.; Nintos, G.; Hatzidaki, D.; Vetsika, E.K.; Mavroudis, D.; Georgoulias, V. Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Small Cell Ovarian Cancer in Adolescents: Report of Two Cases and Review of the Literature. (31st May 2011) Authors: Rovithi, M.; Pallis, A. G.; Kalykaki, A.; Lagoudaki, E.; Giannikaki, L.; Stathopoulos, E. N.; Relakis, K.; Georgoulias, V. Other Names: Aebersold Daniel M. Academic Editor. Journal: Case reports in medicine Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗